Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

被引:32
作者
Gulfe, Anders [1 ]
Aletaha, Daniel [2 ]
Saxne, Tore [1 ]
Geborek, Pierre [1 ]
机构
[1] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden
[2] Med Univ Vienna, Vienna, Austria
关键词
COLLEGE-OF-RHEUMATOLOGY; CLINICAL-PRACTICE; ACTIVITY INDEX; VALIDATION; PREDICTORS; REGISTER; THERAPY;
D O I
10.1186/1471-2474-10-41
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Most composite indices of disease activity and response criteria in RA have been validated and compared in clinical trials rather than routine care. We therefore wanted to compare the performance of the DAS28, SDAI and CDAI activity indices, their activity states, their response criteria, and also compare with the ACR response criteria in an observational clinical setting. Methods: Agreement between the criteria sets was investigated using kappa statistics in a non-randomized cohort of 1789 RA patients from southern Sweden, starting their first course of anti-TNF-treatment. Mean disease duration was 12 years. Completer analysis was used. Results: Agreement between high, moderate and low activity states was moderate or substantial, with. = 0.5 or better for all criteria. Agreement between SDAI and CDAI disease states was > 90% in these categories with kappa > 0.8. DAS28 original and modified cut point remission had good agreement (kappa = 0.91). Agreement between responses was substantial at the overall/ACR20 level (about 95%, kappa = 0.7 or better) for all criteria. By contrast, agreement was poor between moderate and high level responses. Conclusion: Disease activity states according to the various indices perform similarly and show substantial agreement at all levels except remission. Agreement between SDAI and CDAI states is excellent. Response criteria, applied at the individual patient level, are hard to interpret and show poor agreement, except at the lowest level of response. Thus, they should not be applied uncritically in clinical practice.
引用
收藏
页数:8
相关论文
共 16 条
[1]  
Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100
[2]   Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[3]   Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score [J].
Aletaha, D ;
Nell, VP ;
Stamm, T ;
Uffmann, M ;
Pflugbeil, S ;
Machold, K ;
Smolen, JS .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) :R796-R806
[4]  
[Anonymous], BIOMETRICS
[5]   A proposed revision to the ACR20:: The hybrid measure of American College of Rheumatology response [J].
Felson, David ;
Aletaha, Daniel ;
Anderson, Jennifer ;
Bathon, Joan ;
Boers, Maarten ;
Bombardier, Claire ;
Choi, Hyon ;
Dougados, Maxine ;
Furst, Dan ;
Koch, Gary ;
Landewe, Robert ;
LaValley, Mike ;
Michaud, Kaleb ;
Paulus, Hal ;
Pincus, Theodore ;
Siegel, Jeffrey ;
Simon, Lee ;
Smolen, Josef ;
Tugwell, Peter ;
van der Heijde, Desiree ;
White, Barbara ;
Wolfe, Fred ;
Xie, Hui .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (02) :193-202
[6]   AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
FURST, D ;
GOLDSMITH, C ;
KATZ, LM ;
LIGHTFOOT, R ;
PAULUS, H ;
STRAND, V ;
TUGWELL, P ;
WEINBLATT, M ;
WILLIAMS, HJ ;
WOLFE, F ;
KIESZAK, S .
ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735
[7]   Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis [J].
Geborek, P ;
Saxne, T .
RHEUMATOLOGY, 2000, 39 (10) :1159-1161
[8]   Response criteria for rheumatoid arthritis in clinical practice:: how useful are they? [J].
Gülfe, A ;
Geborek, P ;
Saxne, T .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1186-1189
[9]   Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register [J].
Hyrich, K. L. ;
Watson, K. D. ;
Silman, A. J. ;
Symmons, D. P. M. .
RHEUMATOLOGY, 2006, 45 (12) :1558-1565
[10]   Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA:: results from the South Swedish Arthritis Treatment Group Register [J].
Kristensen, L. E. ;
Kapetanovic, M. C. ;
Guelfe, A. ;
Soederlin, M. ;
Saxne, T. ;
Geborek, P. .
RHEUMATOLOGY, 2008, 47 (04) :495-499